These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10861739)

  • 1. Determination of YM992, a novel selective serotonin reuptake inhibitor, in rat and dog plasma by high-performance liquid chromatography with fluorescence detection.
    Noguchi K; Watanabe T; Higuchi S; Chiba K
    Biomed Chromatogr; 2000 Jun; 14(4):269-73. PubMed ID: 10861739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons.
    Szabo ST; Blier P
    J Pharmacol Exp Ther; 2002 Sep; 302(3):983-91. PubMed ID: 12183655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cytochrome P450 isoform involved in the metabolism of YM992, a novel selective serotonin re-uptake inhibitor, in human liver microsomes.
    Noguchi K; Mera A; Watanabe T; Higuchi S; Chiba K
    Xenobiotica; 2000 May; 30(5):503-13. PubMed ID: 10875683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2- [2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino]propi onylamino ) butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84,364) in dog and human plasma by high-performance liquid chromatography.
    Allen MC; Stafford CG; Nocerini MR
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):243-51. PubMed ID: 9323544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
    Takeuchi H; Yatsugi S; Hatanaka K; Nakato K; Hattori H; Sonoda R; Koshiya K; Fujii M; Yamaguchi T
    Eur J Pharmacol; 1997 Jun; 329(1):27-35. PubMed ID: 9218680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
    Higashi Y; Matsumura H; Fujii Y
    Biomed Chromatogr; 2005 Dec; 19(10):771-6. PubMed ID: 15856488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of ABT-089 in human plasma by high performance liquid chromatography using in situ precolumn derivatization with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole.
    Bryan PD; Emry ML; El-Shourbagy TA
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):49-63. PubMed ID: 10704009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity.
    Hatanaka K; Nomura T; Hidaka K; Takeuchi H; Yatsugi S; Fujii M; Yamaguchi T
    Neuropharmacology; 1996; 35(11):1621-6. PubMed ID: 9025110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive HPLC method with automated on-line sample pre-treatment and fluorescence detection for determination of reboxetine in human plasma.
    Khalil NY
    Talanta; 2010 Jan; 80(3):1251-6. PubMed ID: 20006083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):31-6. PubMed ID: 10781670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection.
    Guo X; Fukushima T; Li F; Imai K
    Biomed Chromatogr; 2003 Jan; 17(1):1-5. PubMed ID: 12582998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of sertraline in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry and method validation.
    He L; Feng F; Wu J
    J Chromatogr Sci; 2005; 43(10):532-5. PubMed ID: 16438795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of reboxetine in rat brain microdialysates and plasma samples using liquid chromatography coupled to fluorescence detection.
    Shraim N; Clinckers R; Sarre S; Michotte Y; Van Eeckhaut A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():53-61. PubMed ID: 22560340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of paroxetine in human plasma.
    Naidong W; Eerkes A
    Biomed Chromatogr; 2004 Jan; 18(1):28-36. PubMed ID: 14872546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of YM-64227, a phosphodiesterase type 4 inhibitor, and its five metabolites in dog plasma by high-performance liquid chromatography with fluorescence detection.
    Tenmizu D; Fukunaga Y; Noguchi K; Kamimura H
    Biomed Chromatogr; 2004 Nov; 18(9):667-72. PubMed ID: 15386500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified solvent microextraction with back extraction combined with liquid chromatography-fluorescence detection for the determination of citalopram in human plasma.
    Bagheri H; Khalilian F; Babanezhad E; Es-haghi A; Rouini MR
    Anal Chim Acta; 2008 Mar; 610(2):211-6. PubMed ID: 18291131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatography.
    Hamilton CL; Cornpropst JD
    J Chromatogr; 1993 Feb; 612(2):253-61. PubMed ID: 8468383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive determination of 4-(4-bromophenyl)-4-hydroxypiperidine, a metabolite of bromperidol, in rat plasma by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
    Higashi Y; Nakamura S; Fujii Y
    Biol Pharm Bull; 2006 Dec; 29(12):2479-82. PubMed ID: 17142985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.